Profil
Michael E.
Phillips has been Chairman of Xillix Technologies Corp.
since 2002.
He joined Xillix in 1994.
He was Senior Vice President of Investment for GrowthWorks Capital.
He has over 20 years of direct venture capital experience.
He was Investment Manager for Vencap Equities Albert Ltd.
He received a Bachelor of Commerce degree from Simon Fraser University.
Anciens postes connus de Michael E. Phillips
| Sociétés | Poste | Fin |
|---|---|---|
Biomerge Industries Ltd.
 Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Président | 28/05/2009 |
Formation de Michael E. Phillips
| Simon Fraser University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Biomerge Industries Ltd.
Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Health Technology |
